Reduced medication dependency and improved symptoms and quality of life 12 months after enteryx implantation for gastroesophageal reflux.

@article{Schumacher2005ReducedMD,
  title={Reduced medication dependency and improved symptoms and quality of life 12 months after enteryx implantation for gastroesophageal reflux.},
  author={Brigitte M Schumacher and Horst Neuhaus and Marianne E J Ortner and Ren{\'e} Laugier and Martin Benson and Jean Boyer and Thierry Ponchon and Friedrich Hagenm{\"u}ller and J -C Grimaud and Patrick Rampal and J. Rey and K. Fuchs and H P Allgaier and Juergen H Hochberger and Hubert Jakob Stein and Juan Andr{\'e}s Ram{\'i}rez Armengol and Peter D. Siersema and Jacques Devi{\'e}re},
  journal={Journal of clinical gastroenterology},
  year={2005},
  volume={39 3},
  pages={212-9}
}
BACKGROUND The need is well recognized for additional data on endoluminal therapies for gastroesophageal reflux disease (GERD). This prospective multicenter clinical trial was designed to assess safety and effectiveness of Enteryx, a nonresorbable copolymer implanted into the lower esophagus, in reducing usage of proton pump inhibitors (PPIs) and improving reflux symptoms and quality of life. METHODS Enteryx implantation was performed under fluoroscopic visualization without general… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…